BEST UNLIMITED TURBO SHORT CERTIFICATE - BAYER | Market Closed - Borsa Italiana 20:44:54 26/06/2024 BST | ||
| 5.92 EUR | +4.04% |
|
| Current month | +61.54% | ||
| 1 month | +33.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 26/06/24 | 5.92 | +4.04% |
| 25/06/24 | 5.69 | +5.76% |
| 24/06/24 | 5.38 | -7.72% |
| 21/06/24 | 5.83 | -0.85% |
| 20/06/24 | 5.88 | -5.47% |
Real-time Borsa Italiana
Last update June 26, 2024 at 08:44 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BAYER AG |
| Issuer | 
Société Générale
|
| S34570 | |
| ISIN | DE000SW7EYQ4 |
| Date issued | 12/03/2024 |
| Strike | 31.83 € |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.38 € |
|---|---|
| Lowest since issue | 1.745 € |
| Spread | 0.11 € |
| Spread % | 1.84% |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
26.15
EUR
Average target price
36.18
EUR
Spread / Average Target
+38.36%
- Stock Market
- Certificates
- S34570 Certificat
